Cladribine Venetoclax in Monocytic AML

NCT06232655 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Cladribine
DRUG: Venetoclax
DRUG: Azacitidine

Sponsor

University of Colorado, Denver

Collaborators

[object Object]